RCEL

RCEL Operating Cash Flow Growth

32.39%TTM

Period ending:

RCEL TTM Cash from Operations YoY %%
RCEL TTM Cash from Operations YoY %80.12%-191.27%
2005-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

RCEL operating cash flow growth history

Year-over-year operating cash flow growth rate. The available trailing twelve months (ttm) series contains 81 observations from Dec 31, 2005 to Jun 30, 2026.

Avita Medical Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
32.3947%
19.3466%
36.2574%
34.5759%
32.9986%
22.9268%
-28.7496%
-69.1113%
-119.3013%
-165.0029%
-99.1147%
-48.7404%
-32.8485%
0.0426%
-6.0968%
-9.6055%
29.1263%
32.5355%
42.5489%
41.8298%
18.5133%
15.9865%
-21.5982%
-35.5572%
-64.6805%
-111.6477%
-86.997%
-84.7622%
-54.1213%
-45.4395%
-43.7996%
-72.581%
-79.4049%
-54.3223%
-23.93%
5.3861%
6.9964%
5.4132%
-16.3924%
-46.8948%
-51.5576%
-68.5726%
-47.1238%
6.3102%
22.1068%
34.1916%
35.7584%
25.7212%
13.2099%
4.0418%
-9.7403%
-56.1125%
-68.9669%
-85.7542%
-84.9478%
-67.1441%
-42.8842%
-31.8153%
-55.8999%
-15.6898%
-87.7322%
-30.2712%
3.2025%
-1.6412%
53.8544%
37.1665%
40.0772%
29.7436%
-5.701%
14.8153%
15.0275%
38.9351%
53.5907%
46.7726%
44.4022%
22.1024%
9.3352%
-9.3682%
-4.1951%
-12.2369%
-47.2518%

Compare operating cash flow growth

All RCEL financial metrics · RCEL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.